Onestx
Biotech for neurodegenerative diseases (Alzheimer, Huntington). Drug STX64 (Irosustat): oral steroid sulfatase (STS) inhibitor stabilizing endogenous sulfated neurosteroids. Clinical phase in humans late 2025.
About
Biotech for neurodegenerative diseases (Alzheimer, Huntington). Drug STX64 (Irosustat): oral steroid sulfatase (STS) inhibitor stabilizing endogenous sulfated neurosteroids. Clinical phase in humans late 2025.
Details
- Funding
- €1.4M
- Founded
- 2020
- Website
- onestx.bio